Latest Articles
Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial - Vietnam Investment Review - VIR
Gesynta Pharma reaches 50% patient enrollment milestone in Phase 2 endometriosis trial Vietnam Investment Review - VIR
Published: June 18, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Macau Business
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Macau Business
Published: June 18, 2026, 7:26 a.m.
Awareness gap linked to years-long diagnostic delays for endometriosis patients - b2bnews.co.nz
Awareness gap linked to years-long diagnostic delays for endometriosis patients b2bnews.co.nz
Published: June 18, 2026, 5:16 a.m.
The Role of Molecular Characterization in Precision Medicine in Endometriosis.
Endometriosis is a chronic condition in which tissue similar to the lining of the uterus grows in other parts of the body. It affects roughly 1 in 10 women of …
Published: June 18, 2026, midnight
Motivation to join and supportive activity within online health communities among patients with persistent pain: A survey-based examination.
Online Health Communities (OHCs) are key platforms for people seeking medical information and social support. Individuals with persistent pain often use these communities to better understand their condition, share experiences, …
Published: June 18, 2026, midnight
How femtech is helping fibromyalgia patients - FemTech World
How femtech is helping fibromyalgia patients FemTech World
Published: June 17, 2026, 11:26 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - beQuoted
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat beQuoted
Published: June 17, 2026, 9 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - The Manila Times
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat The Manila Times
Published: June 17, 2026, 8:29 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Yahoo Finance Singapore
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Yahoo Finance Singapore
Published: June 17, 2026, 8:05 a.m.
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat - Dagens industri
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat Dagens industri
Published: June 17, 2026, 7:01 a.m.
Link copied to clipboard!